Skip to content

Dysphagia-optimised intensity modulated radiotherapy versus standard intensity modulated radiotherapy in head and neck cancer cases. kindly note since we are comparing two advanced radiotherapy techniques, this is the simplest public title that can be added.

Dysphagia-Optimised Intensity Modulated Radiation Therapy vs Standard Intensity Modulated Radiation Therapy in post-operative cases of oral cavity carcinoma - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082834
Enrollment
60
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Dyphagia Optimised Intensity Modulated Radiotherapy (DO-IMRT): For patients with oral cavity carcinoma, the intervention arm will be treated with Dysphagia-Optimised Intensity Modulated

Sponsors

Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histologically proven post-operative oral cavity carcinoma. Squamous-cell carcinoma histology. Age 18-70 years of either sex. pT1-pT4, N0-3,M0. ECOG of 0-2. Adequate hematologic, renal and hepatic function.

Exclusion criteria

Exclusion criteria: Pre-existing swallowing dysfunction. Any synchronous or metachronous malignancy. Patients receiving neo-adjuvant chemotherapy. Prior chemotherapy and /or radiotherapy to head and neck region. Incomplete surgery or R2 resection

Design outcomes

Primary

MeasureTime frame
Acute ToxicityTimepoint: 3 months

Secondary

MeasureTime frame
Late toxicity. Disease free survival Overall survival Loco-regional control. Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Lahunshisha Kharbuli

Sir Sunderlal Hospital,Institute of Medical Sciences, BHU.

hmsra1801@gmail.com7704909900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026